# FDA recall D-0744-2021

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2021-07-29.

## Product

Octreotide Acetate Injection 100 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3311-01

## Reason for recall

Lack of Assurance of Sterility

## Distribution

Product was distributed Nationwide, including Puerto Rico.

## Key facts

- **Recall number:** D-0744-2021
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-07-29
- **Report date:** 2021-08-25
- **Termination date:** 2024-06-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0744-2021

## Citation

> AI Analytics. FDA recall D-0744-2021. Retrieved 2026-07-11 from https://api.ai-analytics.org/recall/D-0744-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*